RAMM Pharma Corp. (RAMM.CN)
| Previous Close | 0.0600 |
| Open | 0.0650 |
| Bid | 0.0450 x N/A |
| Ask | 0.0650 x N/A |
| Day's Range | 0.0650 - 0.0650 |
| 52 Week Range | 0.0150 - 0.1200 |
| Volume | |
| Avg. Volume | 44,622 |
| Market Cap | 7.76M |
| Beta (5Y Monthly) | -0.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
RAMM Pharma Corp. Announces Corporate Update
Figure 1 Valeriana Officinalis L. (Valerian Root) TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to advise its shareholders that in accordance with its previously announced strategy of diversifying its product portfolio, in order to reduce its exposure to the strictly regulated environment of Cannabis-based products, it has launched the formulation and production of a full line of botanical-
- GlobeNewswire
RAMM Pharma Corp. Announces Clarification of its Corporate Update of September 12th
TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “Units”) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering”). Each Unit would have been comprised of one common share in the capital of the Company (each, a “Common Share”), and one
- GlobeNewswire
RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid
TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces that it intends to complete a non-brokered private placement of up to 20,000,000 units (the "Units") of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the "Offering"). Each Unit shall be comprised of one common share in the capital of the Company (each, a “Common Share”), and one Common Share purchase warra
